TY - JOUR
T1 - α1-antitrypsin deficiency
T2 - A report from the 2nd meeting of the alpha one international registry, Rapallo (Genoa, Italy), 2001
AU - Luisetti, M.
AU - Miravitlles, M.
AU - Stockley, R. A.
PY - 2002/10/1
Y1 - 2002/10/1
N2 - The Alpha One International Registry is a scientific foundation established to comply with a World Health Organization recommendation to develop a multinational registry of α1-antitrypsin deficiency, with the aim of creating a common database of subjects recognised in a standardised way. A commitment of the Alpha One International Registry members, belonging to 15 national registries, is to meet every 2 yrs; in an open scientific conference to provide a scientific and clinical update on the deficiency. The second Alpha One International Registry meeting was held in Rapallo (Genoa, Italy) on September 27th-28th, 2001, and 26 speakers provided an exhaustive overview of all aspects of α1-antitrypsin deficiency, including epidemiology, genetics, biochemistry, associated conditions, established and novel therapeutic options, and markers of efficacy. In the framework of a rare and often under-recognised condition, this meeting is likely to be central to improving understanding and increasing awareness of α1-antitrypsin deficiency.
AB - The Alpha One International Registry is a scientific foundation established to comply with a World Health Organization recommendation to develop a multinational registry of α1-antitrypsin deficiency, with the aim of creating a common database of subjects recognised in a standardised way. A commitment of the Alpha One International Registry members, belonging to 15 national registries, is to meet every 2 yrs; in an open scientific conference to provide a scientific and clinical update on the deficiency. The second Alpha One International Registry meeting was held in Rapallo (Genoa, Italy) on September 27th-28th, 2001, and 26 speakers provided an exhaustive overview of all aspects of α1-antitrypsin deficiency, including epidemiology, genetics, biochemistry, associated conditions, established and novel therapeutic options, and markers of efficacy. In the framework of a rare and often under-recognised condition, this meeting is likely to be central to improving understanding and increasing awareness of α1-antitrypsin deficiency.
KW - α-antitrypsin deficiency
KW - Epidermiology
KW - Genetics
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=0036771798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036771798&partnerID=8YFLogxK
U2 - 10.1183/09031936.02.00302502
DO - 10.1183/09031936.02.00302502
M3 - Article
C2 - 12412702
AN - SCOPUS:0036771798
SN - 0903-1936
VL - 20
SP - 1050
EP - 1056
JO - European Journal of Respiratory Diseases
JF - European Journal of Respiratory Diseases
IS - 4
ER -